Abstract 137 Table 1

Laboratory Investigations

InvestigationCase 1Case 2Case 3Case 4
Haemoglobin (g/L)94 g/L92 g/L80 g/L69 g/L
White cell counts
Lymphocyte count
6.7×109/L
1.15×109/L
7.2×109/L
1.91×109/L
6.5×109/L
1.65×109/L
6.4×109/L
1.25×109/L
Platelets 130×109/L150×109/L220×109/L90×109/L
Urine routine
Urine protein (mg/m2/hour)
No RBC,
No albumin
No RBC,
No albumin
No RBC,
No albumin
Plenty RBCs, 3+albumin
82 mg/m2/hour
C3 (Normal 50–150 mg/dL)
C4 (Normal 20–50 mg/dL)
27 mg/dl
4 mg/dl
28 mg/dL
3 mg/dL
31 mg/dl
10 mg/dl
21 mg/dl
3 mg/dl
ANA 4+diffuse 3+diffuse3+diffuse4+diffuse
Anti dsDNA (N:<25 IU/mL)59583112346
Antiphospholipid antibodies: a) Lupus anticoagulant b) Anticardiolipin antibody (IgG and IgM) c) Anti ß2 Glycoprotein −1 antibody (IgG and IgM)Positive
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative
2Dimensional EchocardiographyMild pericardial effusion, dilated left ventricle, ejection fraction (EF) 30%Mild pericardial effusion, EF 25%Mild pericardial effusion, moderate mitral regurgitation, mild tricuspid regurgitation, global hypokinesia, EF 56%Moderate mitral regurgitation, mild tricuspid regurgitation, global hypokinesia, EF 18%